These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24807333)

  • 1. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Obstet Gynecol; 2014 Jun; 123(6):1303-1310. PubMed ID: 24807333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
    Robson SJ; Hui L
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
    Wulff CB; Gerds TA; Rode L; Ekelund CK; Petersen OB; Tabor A;
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):38-44. PubMed ID: 26581188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    Chasen ST; McCullough LB; Chervenak FA
    Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive prenatal diagnostic practice in Denmark 1996 to 2006.
    Vestergaard CH; Lidegaard Ø; Tabor A
    Acta Obstet Gynecol Scand; 2009; 88(3):362-5. PubMed ID: 19172424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
    Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
    J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
    Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
    BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England.
    Morgan S; Delbarre A; Ward P
    Ultrasound Obstet Gynecol; 2013 May; 41(5):526-9. PubMed ID: 23297122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
    Calda P; Sípek A; Gregor V
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing.
    Williams J; Rad S; Beauchamp S; Ratousi D; Subramaniam V; Farivar S; Pisarska MD
    Am J Obstet Gynecol; 2015 Jul; 213(1):102.e1-102.e6. PubMed ID: 25882918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sampling and fetal blood sampling.
    Enzensberger C; Pulvermacher C; Degenhardt J; Kawacki A; Germer U; Gembruch U; Krapp M; Weichert J; Axt-Fliedner R
    Ultraschall Med; 2012 Dec; 33(7):E75-E79. PubMed ID: 22623130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of available prenatal screening and diagnosis: effects of the California screen program.
    Blumenfeld YJ; Taylor J; Lee HC; Hudgins L; Sung JF; El-Sayed YY
    J Perinatol; 2012 Dec; 32(12):907-12. PubMed ID: 22402484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
    Johnson K; Kelley J; Saxton V; Walker SP; Hui L
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic disparities in diagnostic testing after positive aneuploidy screening.
    Wong AE; Dungan J; Feinglass J; Grobman WA
    Am J Perinatol; 2015 Feb; 30(2):205-10. PubMed ID: 24936938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.